Join us on
LinkedIn
for the latest news.
Contact
LP Login
What we believe in
what we invest in
who we are
latest from us
Contact
lp login
We use cookies to improve the user experience.
You can read more about our Cookie Policy
here
.
Accept
News & Press
Learn more about recent advances in biotech, health tech and our work.
29.5.2025
Auron Announces First Patient Dosed in Phase 1 Clinical Trial of AUTX-703 in Advanced Hematologic Malignancies
Learn more
Learn more
download pdf
14.5.2025
Therini Bio Raises Additional $39M Series A Financing to Advance Clinical Development of Neurodegenerative Disease Pipeline
Learn more
Learn more
download pdf
8.5.2025
HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases
Learn more
Learn more
download pdf
24.2.2025
Auron Therapeutics Announces AUTX-703 Granted Fast Track Designation by the FDA for Relapsed or Refractory Acute Myelogenous Leukemia
Learn more
Learn more
download pdf
4.2.2025
Auron Therapeutics secures FDA clearance & $27M Series B to advance precision oncology
Learn more
Learn more
download pdf
10.10.2024
Booster Therapeutics launches with $15 M seed financing led by Apollo Health Ventures and Novo Holdings
Learn more
Learn more
download pdf
4.9.2024
HAYA Therapeutics enters partnership with Eli Lilly worth up to $1 B to discover new genome targets for obesity and related metabolic conditions
Learn more
Learn more
download pdf
17.7.2024
GSK enters into a multi-year data licence agreement with Ochre Bio
Learn more
Learn more
download pdf
1 / 4